Incoming and outgoing links Januskinase-Inhibitoren
Back to articleIncoming links
- Abrocitinib
- Prurigo nodularis
- Delgocitinib
- Filgotinib
- JAK-Inhibitoren
- Januskinase-Inhibitoren, atopische Dermatitis
- Januskinase 2
- Januskinasen
- Psoriasis, Therapie und Schwangerschaft
- Ruxolitinib
- STING-associated vasculopathy with onset in infancy
Outgoing links
- Abrocitinib
- Akne (Übersicht)
- Allosterisch
- Baricitinib
- Biologika in der Dermatologie
- CYP2C19-Gen
- CYP2D6-Gen
- CYP3A4
- Cytochrom-P450-Enzyme
- Zytokine
- Delgocitinib
- Deucravacitinib
- Fedratinib
- Filgotinib
- Fluconazol
- Glucuronic acid (INCI)
- Interferone (Übersicht)
- Interleukin-10
- Interleukin-12
- Interleukin-13
- Interleukin-2
- Interleukin-23
- Interleukin-6
- Januskinase 3
- JAK-STAT-Signalweg
- Januskinase 1
- Januskinase 2
- Merkelzell-Karzinom
- Rifampicin
- Ritlecitinib
- Ruxolitinib
- Hautkrebs (Übersicht)
- SOCS
- Thrombose isolierte distale
- TNF-alpha-Antagonisten
- Tofacitinib
- TYK2
- Tyrosinkinase 2
- Upadacitinib
- Varizella-Zoster-Virus